• Prestained Protein Marker: Triple-Color Workflow Guide

  2026-09-02

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides visible size landmarks for SDS-PAGE and Western blot transfer checks across a broad molecular-weight range. It is intended for denaturing gel and membrane workflows, including Phosbind and fluorescent imaging applications, but should not be treated as standalone evidence of protein identity or native-PAGE performance.

• Ranolazine Workflows for Ischemia Research

  2026-09-02

  Use Ranolazine as both a late sodium current inhibitor and a metabolic probe in cardiac ischemia research. This workflow connects myocardial relaxation and substrate utilization assays with a carefully bounded exploratory framework for liver-cell autophagy and innate-immunity studies.

• DDM and the Dynamic Integrin Challenge

  2026-09-01

  Full-length αvβ3 integrin exists as a dynamic ensemble rather than a single druggable shape. This thought-leadership guide explains how n-Dodecyl-β-D-maltoside (DDM) can become a deliberate variable in integrin purification, cryo-EM sample preparation, folding assays, and translational screening—while emphasizing the controls needed to distinguish genuine biology from detergent-induced states.

• ABT-737: Mapping Mitochondrial Apoptosis

  2026-09-01

  ABT-737 is a selective BCL-2 protein inhibitor that helps researchers dissect mitochondrial apoptosis rather than merely measure cell death. This article connects its BH3-mimetic pharmacology with assay design, BAX/BAK biology, and interpretation of cancer-model responses.

• SINAT–VAB1 Control of Plant Autophagy

  2026-08-31

  A 2026 study in Arabidopsis identifies VAB1, a V-ATPase subunit, as a direct SINAT-associated regulator of autophagic vesicle degradation. By connecting SINAT-dependent ubiquitination of VAB1 with vacuolar acidification, the work distinguishes control of autophagic cargo breakdown from autophagosome formation and links this pathway to nutrient-stress tolerance and leaf senescence.

• Precision PCR for Neurodegeneration Research

  2026-08-31

  A translational strategy for using HyperFusion™ high-fidelity DNA polymerase to improve the accuracy, robustness, and interpretability of neurogenetic workflows inspired by pheromone-driven neurodegeneration research in C. elegans.

• Exemestane: Mechanism to Translational Strategy

  2026-08-30

  Exemestane is more than an aromatase assay reagent: its steroidal structure and irreversible enzyme inactivation create a powerful framework for connecting target engagement with estrogen-dependent phenotypes. This thought-leadership guide shows how translational researchers can position Exemestane within biomarker-led breast cancer research, compare it thoughtfully with SERM-based strategies, and design experiments that preserve mechanistic interpretability.

• Wnt-C59: Practical PORCN Inhibition Workflows

  2026-08-29

  Wnt-C59 enables precise testing of Wnt secretion, pathway activation, and Wnt-driven cancer phenotypes without relying solely on downstream pathway readouts. This guide translates its PORCN-focused activity into reproducible reporter, cholangiocarcinoma, and exploratory exosome workflows while clearly separating established evidence from future applications.

• PTT–CD47 Synergy in Oral Squamous Cell Carcinoma

  2026-08-28

  The reference study shows that photothermal therapy and CD47 blockade cooperate through two complementary mechanisms: photothermal treatment exposes calreticulin as an eat-me signal and remodels the extracellular matrix to improve macrophage access. Its integrated use of phagocytosis assays, immunogenic cell-death measurements, spatial imaging, and tumor-growth analysis provides a mechanistic framework for strengthening macrophage-based immunotherapy in oral squamous cell carcinoma.

• Apigenin: From HDAC Biology to Assay Design

  2026-08-28

  Apigenin research is strongest when chromatin regulation, apoptosis, reactive oxygen species production, and neuroinflammatory signaling are measured as connected events. This guide translates those mechanisms into a context-aware assay strategy for malignant mesothelioma and neurodegeneration studies.

• Angiotensin II: From GPCR Signals to Aneurysm Models

  2026-08-27

  Angiotensin II research can connect receptor-proximal signaling with vascular remodeling and aneurysm biology. This article presents a decision framework that combines Angiotensin II perturbation models with recent evidence on mitochondrial NAD+ deficiency and collagen III turnover.

• HDAC Inhibitors Repress NUT Function in NUT Carcinoma

  2026-08-27

  Shiota and colleagues developed a dCas9-based high-throughput reporter screen that identified chemically diverse HDAC inhibitors as repressors of BRD4-NUT transcriptional activity. Their mechanistic and xenograft data connect HDAC inhibition with megadomain disruption, oncogene repression, differentiation, and improved tumor control when combined with bromodomain inhibition.

• Olive Biophenols Reduce Aβ42 Pathology in AD Models

  2026-08-26

  The reference study links olive-derived biophenols with reduced Aβ42 aggregation, oxidative stress, and plaque deposition across SH-SY5Y cells and APPswe/PS1dE9 mice. Its main contribution is a connected in vitro–in vivo design that evaluates both direct anti-amyloid activity and protection from Aβ42-associated toxicity.

• CHIR 99021 Trihydrochloride in Organoid Assays

  2026-08-26

  CHIR 99021 trihydrochloride is a potent GSK-3 inhibitor for dissecting stemness, differentiation, and metabolic signaling. This guide translates recent human intestinal organoid findings into practical assay-design decisions, emphasizing dose logic, reversible state control, and biologically meaningful readouts.

• Dose- and Time-Dependent Ibotenic Acid Toxicity

  2026-08-25

  A 2026 mouse study provides an integrated analysis of ibotenic acid toxicity across behavioral, biochemical, histological, and immunohistochemical endpoints. Its findings distinguish reversible early responses from severe high-dose injury and offer practical guidance for interpreting ibotenic acid exposure in toxicology and neuroscience research.

7909 records 1/528 page Next 12345 下5页 Last page